Prabowo Aims for Sabang and Andaman-Nicobar as Economic Links between Indonesia and India
-
News
-
1 minute ago
This article was translated by AI. Read the original article on Kompas.com. See Original
JAKARTA, KOMPAS.com - Indonesian President Prabowo Subianto has urged the head of the National Research and Innovation Agency (BRIN), Arif Satria, to expedite research related to malaria vaccines.
"The President is asking for the research process on this vaccine to be accelerated," Arif said after meeting with President Prabowo Subianto at the Presidential Complex in Jakarta on Tuesday (27/10/2026).
With Prabowo's support, Arif hopes that the malaria vaccine can be completed within three years.
"We can expedite this by three years compared to the original timeline, as he is committed to providing full support for the production of this vaccine, especially the malaria vaccine," he stated.
Arif noted that there is currently no vaccine in the world for malaria caused by the parasite Plasmodium vivax.
Therefore, Indonesia could contribute to global health once the malaria vaccine research led by BRIN is completed.
"If we can produce it in Indonesia, this could be Indonesia’s contribution to the world. The President emphasized our role in global contributions as well," he said.
Moreover, malaria is not only an issue in Indonesia, so the results of the vaccine research could be beneficial worldwide.
"Since malaria exists globally and there is currently no vaccine, we can contribute to the welfare of people around the world," he added.
According to Arif, Prabowo is very attentive to the progress of the malaria vaccine.
He noted that the President has called him multiple times to inquire about the vaccine's development.
"The President has called me several times to ask about the vaccine, especially regarding vaccine independence. So, this particular vaccine for malaria is currently being researched at BRIN, which has four vaccine candidates," he explained.
BRIN is also collaborating with the Ministry of Health and Bio Farma in developing this vaccine.
"In total, there are approximately five or six vaccine candidates in Indonesia, and we are working in partnership with various parties, including the Ministry of Health and Bio Farma," he said.
In addition to vaccines, Prabowo is also said to be focusing on herbal medicines and drug independence.
He has instructed that this independence in pharmaceuticals needs to be realized promptly.
"I believe herbal medicines are very promising, and BRIN has also collaborated with various entities to accelerate the process of developing herbal remedies," Arif stated.
He added that BRIN has 19 herbal medicine candidates that are under consideration for fitofarmaka.
This initiative will be coordinated with the Ministry of Health and BPOM to facilitate acceleration.
"Several herbal medications at BRIN are currently in the stage of OHT, or standardized herbal medicines. Now, we aim to transition toward fitofarmaka. Getting to fitofarmaka requires various clinical trials," he explained.